Please login to the form below

Not currently logged in
Email:
Password:

Ziarco

This page shows the latest Ziarco news and features for those working in and with pharma, biotech and healthcare.

Daily brief: Novartis spends big on ezcema, Kite invests, another gene therapy IPO

Daily brief: Novartis spends big on ezcema, Kite invests, another gene therapy IPO

Novartis already has ZPL389 in its pipeline, a phase II ezcema treatment it gained with the acquisition of Ziarco two years ago.

Latest news

  • Novartis adds oral eczema drug with Ziarco acquisition Novartis adds oral eczema drug with Ziarco acquisition

    Expands dermatology pipeline with first-in-class, Pfizer-developed treatment prospect. Novartis has bolstered its dermatology portfolio by buying UK firm Ziarco, bolting on a first-in-class oral therapy for ... Ziarco's lead product is ZPL389, an

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Ziarco appoints Mike Grey to board of directors Ziarco appoints Mike Grey to board of directors

    I look forward to working with the Ziarco team to help grow the company and propel its product candidates forward.”. ... Ed Mathers, chairman of Ziarco, commented: “We are thrilled to welcome Mike to Ziarco's board of directors.

  • Former Pfizer R&D head LaMattina to advise Ziarco Former Pfizer R&D head LaMattina to advise Ziarco

    He previously spent 30 years at US pharma firm. UK-based biotech Ziarco has hired former head of R&D at Pfizer, Dr John LaMattina, as a strategic R&D adviser. ... In his new role, he will help Ziarco to advance its development strategies for its

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GK Strategy

GK is award-winning independent communications agency specialising in delivering impactful strategies for clients across the healthcare market....

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics